SB256 Establishing safety and care requirements for clinician-administered drugs.
Establishing safety and care requirements for clinician-administered drugs.
Impact Score — How Does This Bill Affect You?
Overall Impact Score
Mixed
Scale: 1 (harmful) to 10 (beneficial)
Your Wallet
Could increase costs for some treatments due to new requirements, but also prevents unsafe cost-cutting.
Your Community
Enhances patient safety standards for clinician-administered treatments like infusions and injections.
Your Freedom
Standard safety regulation; no significant impact on personal liberties.
Status
Refer for Interim Study: Motion Adopted Voice Vote 05/14/2026 House Journal 13
Sponsor
Tim McGough (R)
The Short Version
Would establish safety and care standards for drugs administered directly by clinicians, such as infusion therapies. Aims to ensure proper oversight and patient safety for treatments given in clinical settings.
Who's Behind This Bill?
Who Benefits
- ▲ Patients receiving clinician-administered drugs
- ▲ Healthcare providers seeking clear safety standards
Who Pays the Price
- ▼ Clinics that may need to invest in meeting new safety requirements
Bill statuses as of May 2026. Check LegiScan or NH General Court for the latest.
This bill was auto-scored using AI analysis of the bill text and legislative data. Scores may be refined as we review more bills.